A validated surrogate analyte LC-MS/MS assay for quantification of endogenous cortisol in human whole blood

被引:8
|
作者
Agrawal, Karan [1 ]
Voggu, Ramakrishna R. [1 ]
Pisek, Daniel [1 ]
Becht, Steven [2 ]
Chudnovskiy, Ross [1 ]
Dufour, Geraldine Mercier [3 ]
Arfvidsson, Cecilia [4 ]
Thomas, C. Eric [1 ]
机构
[1] Covance Labs Inc, 8211 SciCor Dr, Indianapolis, IN 46214 USA
[2] Covance Labs Inc, 3301 Kinsman Blvd, Madison, WI 53704 USA
[3] Covance Labs Inc, Otley Rd, Harrogate HG3 1PY, England
[4] AstraZeneca R&D, Clin Pharmacol & Safety Sci, Quantitat Pharmacol Clin Pharmacol, Gothenburg, Sweden
关键词
Cortisol; Whole blood; LC-MS/MS; Surrogate analyte; Supported liquid extraction; Bioanalysis; TANDEM MASS-SPECTROMETRY; QUANTITATION; AGREEMENT; PLASMA;
D O I
10.1016/j.jpba.2021.114028
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Cortisol is a steroid hormone that is frequently measured as a marker of stress, inflammation, and immune function. While commonly analyzed in saliva, hair, blood plasma and urine, a recent trend towards whole blood-based at-home collection devices has emerged, which necessitates development of more sensitive assays for cortisol in whole blood. To support the implementation of a patient-centric sampling approach in a drug development program, a fit-for-purpose surrogate analyte-based liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for cortisol in whole blood was developed using C-13(3)-cortisol as a surrogate analyte and cortisol-d6 as the internal standard. The surrogate analyte approach was chosen due to a lack of available cortisol-free whole blood and the absence of appropriately representative surrogate matrices. Samples were prepared using supported liquid extraction, and the LC-MS/MS analysis consisted of a 4.00 min analytical run. The method demonstrated linearity between 0.500 and 500 ng/mL of C-13(3)-cortisol, and accuracy, precision and robustness were all acceptable per current regulatory guidance for bioanalytical method validation of chromatographic assays for cortisol- and C-13(3)-cortisol-based quality control (QC) samples when quantified against a C-13(3)-cortisol calibration curve. The acceptable robustness of cortisol-based QCs when quantified against a C-13(3)-cortisol-based calibration curve also suggests parallelism between the analytes. These results indicate a viable surrogate analyte method, that is fit-for-purpose to analyze whole blood cortisol levels using a surrogate analyte LC-MS/MS approach. Evaluation of patient samples showed very promising comparability between whole blood and plasma cortisol concentrations, suggesting that whole blood could be used in place of or in addition to a plasma-based sampling protocol in clinical trials analyzing cortisol. Overall, this method presents a novel tool that is a first step in supporting the trend towards sample miniaturization and at-home sample collection, and may be readily used in clinical and diagnostic settings. (C) 2021 Elsevier B.V. All rights reserved.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] A Sensitive LC-MS/MS Assay for Total Testosterone Quantification
    Cao, W.
    Wolken, J. K.
    Peterson, M. M.
    Challoner, K. E.
    Jin, Z.
    CLINICAL CHEMISTRY, 2024, 70
  • [22] Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionization
    Beyer, Jochen
    Peters, Frank T.
    Kraemer, Thomas
    Maurer, Hans H.
    JOURNAL OF MASS SPECTROMETRY, 2007, 42 (02): : 150 - 160
  • [23] A validated LC-MS/MS method for the quantification of bevacizumab in rat, cynomolgus monkey, and human serum
    Zhou, Ainan
    Yu, Jinghua
    Wu, Yali
    Xue, Hao
    Zhong, Dafang
    Diao, Xingxing
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2023, 235
  • [24] Comparison of two immunoassays with an LC-MS/MS assay for serum cortisol
    Owen, L.
    Wear, J.
    Keevil, B.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A106 - A106
  • [25] Validated extended multiplexed LC-MS/MS assay for the quantification of adagrasib and sotorasib in human plasma, together with four additional SMIs
    Kruithof, Paul D.
    de Beer, Yvo M.
    Gulikers, Judith L.
    Stolk, Leo M. L.
    Hendriks, Lizza E. L.
    Croes, Sander
    van Geel, Robin M. J. M.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2023, 1231
  • [26] A surrogate analyte-based LC-MS/MS method for the determination of γ-hydroxybutyrate (GHB) in human urine and variation of endogenous urinary concentrations of GHB
    Kang, Soyoung
    Oh, Seung Min
    Chung, Kyu Hyuck
    Lee, Sooyeun
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 98 : 193 - 200
  • [27] Development of a validated LC-MS/MS method for the quantification of 19 endogenous asthma/COPD potential urinary biomarkers
    Khamis, Mona M.
    Adamko, Darryl J.
    El-Aneed, Anas
    ANALYTICA CHIMICA ACTA, 2017, 989 : 45 - 58
  • [28] Quantification of vancomycin in human serum by LC-MS/MS
    Koenig, Katrin
    Kobold, Uwe
    Fink, Gerhard
    Leinenbach, Andreas
    Duelffer, Thomas
    Thiele, Roland
    Zander, Johannes
    Vogeser, Michael
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (09) : 1761 - 1769
  • [29] Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA
    Millet, Aurelien
    Khoudour, Nihel
    Bros, Pauline
    Lebert, Dorothee
    Picard, Guillaume
    Machon, Christelle
    Goldwasser, Francois
    Blanchet, Benoit
    Guitton, Jerome
    TALANTA, 2021, 224
  • [30] Quantitation of 2-hydroxyglutarate in human plasma via LC-MS/MS using a surrogate analyte approach
    Yin, Feng
    Ling, Yonghua
    Keller, Jennifer
    Kraus, Dennis
    Narayanaswamy, Rohini
    Mangus, Heidi
    Li, Fumin
    Yang, Hua
    Liu, Guowen
    BIOANALYSIS, 2020, 12 (16) : 1149 - 1159